The Changing Oncology Landscape: Evolution or Revolution? A Roundtable Discussion
Learning Objectives
At the conclusion of this session, the participant should be able to:
- Describe key changes in the oncology landscape
Clifford Goodman, PhD (Moderator)
The Lewin Group
Roy Beveridge, MD
Chief Medical Officer
McKesson Specialty Health
John Fox, MD, MHA
Associate Vice President of Medical Affairs
Priority Health
Martin Kohn, MD, MS
Chief Medical Scientist, Care Delivery Systems
IBM Research
John J. “Jack” Mahoney, MD, MPH
Chief Medical Officer
Florida Health Care Coalition
Lee N. Newcomer, MD, MHA
Senior Vice President, Oncology, Genetics and Women’s Health
UnitedHealthcare
Kavita Patel, MD, MSHS
Managing Director for Clinical Transformation and Delivery
The Brookings Institution Engelberg Center for Health Care Reform
Andrew von Eschenbach, MD
President
Samaritan Health Initiatives
Available Credit
- 1.25 Case Manager
- 1.25 Participation
- 1.25 Nurse
- 1.25 Pharmacist
- 1.25 Physician
- 1.25 Tumor Registrar